About airis PHARMA
airis PHARMA is a Healthcare company based in Hyderabad (India) founded in 2015. It develops and supplies generic drugs including oral solids and injectables internationally. It operates on a B2B and Manufacturing model. The company has 47 employees. Its Indian entity Airis Pharma Private Limited reported revenue of ₹9.06 Cr. airis PHARMA offers products and services including Aminocaproic Acid Oral Solution, Generic Formulation Products, and Analytical Quality Services. Its focus areas include Pharmaceuticals, Generic Drugs, Formulation Development and Quality Services. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
airis PHARMA focuses on developing generic formulation products ranging from oral solids to injectables, emphasizing high entry barriers and continuous quality. Based in Hyderabad, India, it provides research and development services, analytical testing for raw materials and drug products, and stability storage under ICH conditions. The company targets markets such as the US, Europe, NZ-Aus, Turkey, and UK, with approvals like ANDA for specific drugs.
- Headquarters Hyderabad, India
- Employees 47
- SectorsHealthcare
- Email••••••••
- Website airispharma.com
- Legal Name Airis Pharma Private Limited
- Date of Incorporation 19 Aug, 2013
- Jurisdiction Telangana, India
- Annual Revenue₹9.06 Cr
FY 2024 · +29% YoY
- Net Loss-₹77.3 Lakh
FY 2024 · -9% margin
- EBITDA₹76.6 Lakh
FY 2024 · 8% margin
- Employee Count47
Associated legal entities of airis PHARMA
airis PHARMA operates through Airis Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Airis Pharma Private Limited CIN U24232TG2013PTC089550 | Active | 19 Aug 2013 | Hyderabad, Telangana | ₹9.1 Cr | 47 | 7 | View details |
Products & Services of airis PHARMA
airis PHARMA offers a comprehensive portfolio of products and services, including Aminocaproic Acid Oral Solution, Generic Formulation Products, and Analytical Quality Services.
Prevents and treats excessive bleeding in surgical procedures.
Develops high-quality oral solids and injectables for global markets.
Conducts raw material and drug product testing for compliance.
Board of directors of Airis Pharma Private Limited (airis PHARMA)
Airis Pharma Private Limited is the primary company behind airis PHARMA. The board of Airis Pharma Private Limited currently have 7 directors; the longest-serving is Ganji Kishore Kumar, appointed in 2013. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ganji Kishore Kumar DIN 01973900 | Director | 30 Aug 2013 | 13 yrs 1 mo | Airis Pharma Private Limited |
| Ajoy Pavan Kumar Koppolu Yerakaliah DIN 06674155 | Director | 30 Aug 2013 | 13 yrs 1 mo | Airis Pharma Private Limited |
| Mohan Reddy Patalolla DIN 02408561 | Director | 16 Jan 2017 | 9 yrs 9 mo | Airis Pharma Private Limited |
| Gantla Shailaja DIN 02419869 | Director | 21 Sep 2020 | 6 yrs 1 mo | Airis Pharma Private Limited |
| Srilalitha Bhattaram DIN 08880098 | Director | 21 Sep 2020 | 6 yrs 1 mo | Airis Pharma Private Limited |
| Venkata Bhattaram Chandra Sekhar DIN 06831098 | Director | 21 Jul 2025 | 1 yr 3 mo | Airis Pharma Private Limited |
| Suchritha Reddy Patlolla DIN 11354428 | Director | 05 Jan 2026 | 9 mo | Airis Pharma Private Limited |
Financials of airis PHARMA
Figures of Airis Pharma Private Limited, the primary company behind airis PHARMA, for FY 2024. Revenue was ₹9.06 Cr (+29% year on year). Net loss was -₹77.3 Lakh (-9% margin). EBITDA was ₹76.6 Lakh (8% margin). Revenue has grown at a compounded annual rate of +32% over three years and +92% over five years.
- ₹9.06 CrRevenue · FY 2024 · +29% YoY
- -₹77.3 LakhNet loss · -9% margin
- ₹76.6 LakhEBITDA · 8% margin
- ₹7.52 CrPaid-up capital
- 47Employees (provident fund records)
- +32%Revenue CAGR, 3 years
- +92%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Airis Pharma Private Limited are on its company page.
Detailed financial statements for airis PHARMA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to airis PHARMA
airis PHARMA has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of airis PHARMA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Airis Pharma
Complete news archive for airis PHARMA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about airis PHARMA
airis PHARMA was founded in 2015.
airis PHARMA is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
airis PHARMA has 47 employees.
The primary company behind airis PHARMA, Airis Pharma Private Limited, reported revenue of ₹9.06 Cr for FY 2024, up 29% year on year.
airis PHARMA focuses on developing generic formulation products ranging from oral solids to injectables, emphasizing high entry barriers and continuous quality. Based in Hyderabad, India, it provides research and development services, analytical testing for raw materials and drug products, and stability storage under ICH conditions. The company targets markets such as the US, Europe, NZ-Aus, Turkey, and UK, with approvals like ANDA for specific drugs.
airis PHARMA's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
airis PHARMA offers Aminocaproic Acid Oral Solution, Generic Formulation Products, and Analytical Quality Services.
airis PHARMA operates through Airis Pharma Private Limited.
The legal entities of airis PHARMA currently have 7 directors, including Venkata Bhattaram Chandra Sekhar, Mohan Reddy Patalolla, Ganji Kishore Kumar and others.